Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:55 AM
Ignite Modification Date:
2025-12-25 @ 12:55 AM
NCT ID:
NCT01660867
Eligibility Criteria:
Inclusion Criteria:
* 3mo \~ 24mo aged patients with bronchiolitis visit to emergency departments
* RDAI score 4-15
Exclusion Criteria:
* \< 3mo, \> 24mo
* infants who had received oral or inhaled corticosteroids during the preceding 2 weeks
* infants with a previous episode of wheezing or a diagnosis of asthma
* any chronic cardiopulmonary disease
* immunodeficiency
* infants needed intubation
* infants with a previous history of apnea or intubation
* infants with side effect of dexamethasone
* infants born at less than 37 weeks of gestation who had a corrected age of less than 6 weeks at presentation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
3 Months
Maximum Age:
24 Months
Study:
NCT01660867
Study Brief:
Protocol Section:
NCT01660867